A Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Condition:   Cutaneous Lupus Erythematosus Interventions:   Combination Product: Anifrolumab;   Other: Placebo Sponsors:   AstraZeneca;   Parexel Not yet recruiting

Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials